Editas Medicine CEO James Mullen's 2021 pay jumps 354% to $6.7M
Editas Medicine reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Editas Medicine reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, six executives at Editas Medicine received on average a compensation package of $2.6M, a 28% increase compared to previous year.
Average pay of disclosed executives at Editas Medicine
James Mullen, Chief Executive Officer, received $6.7M in total. 86% of Mullen's compensation, or $5.8M, was in option awards. Mullen also received $362K in non-equity incentive plan, $541K in salary, as well as $32K in other compensation.
For fiscal year 2021, the median employee pay was $181,354 at Editas Medicine. Therefore, the ratio of James Mullen's pay to the median employee pay was 37 to one.
Mark Shearman, Chief Scientific Officer, received a compensation package of $3.5M. 45% of the compensation package, or $1.6M, was in stock awards.
Michelle Robertson, Chief Financial Officer, earned $2.2M in 2021, a 38% decrease compared to previous year.
Bruce Eaton, Executive Vice President and Chief Business Officer, received $1.8M in 2021.
Lisa Michaels, Chief Medical Officer, earned $823K in 2021, a 74% decrease compared to previous year.
Cynthia Collins, Chief Executive Officer, received $662K in 2021, which decreases by 79% compared to 2020.
Related executives
James Mullen
Editas Medicine
Chief Executive Officer
Michelle Robertson
Editas Medicine
Chief Financial Officer
Mark Shearman
Editas Medicine
Chief Scientific Officer
Bruce Eaton
Editas Medicine
Executive Vice President and Chief Business Officer
Lisa Michaels
Editas Medicine
Chief Medical Officer
Cynthia Collins
Editas Medicine
Chief Executive Officer
You may also like
Source: SEC filing on April 26, 2022.